Robotic Surgery
Add to your list(s)
Download to your calendar using vCal
If you have a question about this talk, please contact Dr Nigel Bennee.
Professor Neal will elucidate the underlying factors of prostate cancer, and the merits of screening. Prostate cancer is the most common solid tumour found in men and accounts for about 35,000 new cases each year in the UK. About 10,000 men die each year from it. The prostate gland is small, weighing around 20g, and its development is strongly driven by the male sex hormone testosterone and its receptor the androgen receptor. Some recent advances in our understanding of the molecular biology of the disease will be described.
Some recent clinical trials on screening will be reviewed and some recent data on genetic predisposition for the disease will be outlined. Professor Neal will finish with a review of his experience in carrying out over 500 robotic prostatectomy operations.
This talk is part of the Cambridge Society for the Application of Research (CSAR) series.
This talk is included in these lists:
Note that ex-directory lists are not shown.
|